相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emergence of Resistance to Ceftazidime-Avibactam in a Pseudomonas aeruginosa Isolate Producing Derepressed blaPDC in a Hollow-Fiber Infection Model
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Pharmacodynamics of Ceftazidime plus Avibactam against KPC-2-Bearing Isolates of Klebsiella pneumoniae in a Hollow Fiber Infection Model
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Molecular mechanisms of polymyxin resistance and detection of mcr genes
Patrik Mlynarcik et al.
BIOMEDICAL PAPERS-OLOMOUC (2019)
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment
Karen P. H. Mattos et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniaein mouse thigh and lung infection models
Cornelia B. Landersdorfer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy
Alexandre P. Zavascki et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia
George L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli
Nicholas M. Smith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
Justin R. Lenhard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The development and validation of a simple liquid chromatography-tandem mass spectrometry method for polymyxin B1 and B2 quantification in different matrices
Jenna Covelli et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review
David M. Jacobs et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Thien B. Tran et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Polymyxin: Alternative Mechanisms of Action and Resistance
Michael J. Trimble et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, Sao Paulo, Brazil
Flavia Bartolleti et al.
EMERGING INFECTIOUS DISEASES (2016)
Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
Brian C. Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
F. Docobo-Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media
Soon-Ee Cheah et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Hollow-Fiber Pharmacodynamic Studies and Mathematical Modeling To Predict the Efficacy of Amoxicillin for Anthrax Postexposure Prophylaxis in Pregnant Women and Children
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Two-Component System CprRS Senses Cationic Peptides and Triggers Adaptive Resistance in Pseudomonas aeruginosa Independently of ParRS
Luca Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005-2010
Benedikt Huttner et al.
PLOS ONE (2012)
Resistance to polymyxins: Mechanisms, frequency and treatment options
Matthew E. Falagas et al.
DRUG RESISTANCE UPDATES (2010)
Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43
Hsin-Yao Cheng et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial
V. H. Tam et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Gram-negative outer and inner membrane models: Insertion of cyclic cationic lipopeptides
Adria Clausell et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2007)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bacterial-population responses to drug-selective pressure:: Examination of garenoxacin's effect on Pseudomonas aeruginosa
VH Tam et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Molecular basis of bacterial outer membrane permeability revisited
H Nikaido
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
分享论文
